Peripheral levels of glutathione and protein oxidation as markers in the development of Alzheimer's disease from Mild Cognitive Impairment

被引:135
|
作者
Bermejo, Paloma [1 ]
Martin-Aragon, Sagrario [1 ]
Benedi, Juana [1 ]
Susin, Cristina [1 ]
Felici, Emanuela [1 ]
Gil, Pedro [2 ]
Ribera, Jose Manuel [2 ]
Villar, Angel Ma [1 ]
机构
[1] Univ Complutense Madrid, Fac Farm, Dept Farmacol, Madrid 28040, Spain
[2] Hosp Univ Clin San Carlos, Serv Geriatr, Madrid 28040, Spain
基金
新加坡国家研究基金会;
关键词
oxidative stress; Alzheimer's disease; Mild Cognitive Impairment; glutathione; protein carbonyls;
D O I
10.1080/10715760701861373
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
There is a great interest in the relationship between Mild Cognitive Impairment (MCI) and the progression to Alzheimer's disease (AD). Several studies show the importance of oxidative stress in the pathogenesis of AD. The purpose of this study was the link between oxidative damage, MCI and AD. It analysed protein carbonyls and erythrocyte glutathione system plasma levels of 34 subjects with MCI, 45 subjects with AD and 28 age-matched control subjects. The results showed an increase in protein modification, a decrease in GSH levels and GSH/GSSG ratio in AD and MCI patients compared to age-matched control subjects (p < 0.05). The present study shows that some peripheral markers of oxidative stress appear in MCI with a similar pattern to that observed in AD, which suggests that oxidative stress might represent a signal of the AD pathology. AD and MCI are biochemically equivalent. MCI does not necessarily need to progress to AD on a biochemical level.
引用
收藏
页码:162 / 170
页数:9
相关论文
共 50 条
  • [41] Galantamine for Alzheimer's disease and mild cognitive impairment
    Cusi, Cristina
    Cantisani, Teresa Anna
    Celani, Maria Grazia
    Incorvaia, Barbara
    Righetti, Enrico
    Candelise, Livia
    [J]. NEUROEPIDEMIOLOGY, 2007, 28 (02) : 116 - 117
  • [42] Mild cognitive impairment and preclinical Alzheimer's disease
    Morris, JC
    [J]. GERIATRICS-US, 2005, : 9 - 14
  • [43] The fornix in mild cognitive impairment and Alzheimer's disease
    Nowrangi, Milap A.
    Rosenberg, Paul B.
    [J]. FRONTIERS IN AGING NEUROSCIENCE, 2015, 7
  • [44] Dysgraphia in Alzheimer's disease with mild cognitive impairment
    Kavrie, S
    Neils-Strunjas, J
    [J]. JOURNAL OF MEDICAL SPEECH-LANGUAGE PATHOLOGY, 2002, 10 (01) : 73 - 85
  • [45] Mild cognitive impairment: Aging to Alzheimer's disease
    Price, CC
    McCoy, KJM
    [J]. CLINICAL NEUROPSYCHOLOGIST, 2004, 18 (02): : 204 - 207
  • [46] Aging, mild cognitive impairment, and Alzheimer's disease
    Petersen, RC
    [J]. NEUROLOGIC CLINICS, 2000, 18 (04) : 789 - +
  • [47] MRI in Alzheimer's disease and mild cognitive impairment
    Jack, CR
    [J]. BIOLOGICAL PSYCHIATRY, 2005, 57 (08) : 4S - 4S
  • [48] Galantamine for Alzheimer's disease and mild cognitive impairment
    Loy, C
    Schneider, L
    [J]. COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2006, (01):
  • [49] Neuropathology of Alzheimer's disease and mild cognitive impairment
    López, OL
    DeKosky, ST
    [J]. REVISTA DE NEUROLOGIA, 2003, 37 (02) : 155 - 163
  • [50] Taste in mild cognitive impairment and Alzheimer's disease
    Steinbach, Silke
    Hundt, Walter
    Vaitl, Andreas
    Heinrich, Petra
    Foerster, Stefan
    Buerger, Katharina
    Zahnert, Thomas
    [J]. JOURNAL OF NEUROLOGY, 2010, 257 (02) : 238 - 246